With the approval of The University of Texas System Board of Regents recently, The University of Texas MD Anderson Cancer Center is one step closer to developing and building its own outpatient diagnostic and treatment center to better serve the growing communities of West Houston and beyond.
The new center will be the first free-standing clinical building that MD Anderson has constructed outside the Texas Medical Center.
The center will be built on 36 acres of land owned by MD Anderson, near the intersection of Interstate 10 and Highway 6. When it opens to patients in 2018, the building will be approximately 175,000 square feet.
“It’s great to get the green light from the Board of Regents to start work on a new facility that will give the residents of West Houston and the surrounding region even greater access to MD Anderson specialty services, care, research, and diagnostics,” said Thomas Burke, M.D., executive vice president, MD Anderson Cancer Network®.
“Our mission to end cancer charges us with expanding and adapting programs that best reflect and respond to the needs of our patients, and this new center demonstrates that commitment.”
The Board of Regents action also approved a first-ever clinical collaboration agreement between MD Anderson and The University of Texas Medical Branch at Galveston which will include construction of an outpatient cancer center on UTMB’s campus in League City.
The newly approved MD Anderson outpatient center is expected to open by 2018 and encompass about 135,000 square feet. It will complement UTMB’s inpatient facility on the same campus.